Drug Information Services Today: Current Role and Future Perspectives in Rational Drug Therapy

• Published in: Clinical therapeutics Vol. 38; no. 2; pp. 414 - 421
• Main Authors: Amundstuen Reppe, Linda, MSc, Spigset, Olav, MD, PhD, Schjøtt, Jan, MD, PhD
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.02.2016; Elsevier Limited
• Subjects: Conflicts of interest; Diabetes; Disease; Drug Industry; drug information services; Drug Information Services - trends; Drug therapy; evidence-based medicine; Family physicians; Funding; health information management; Health Personnel; Humans; inappropriate prescribing; Internal Medicine; Medical Education; Medicine; Pharmacists - organization & administration; Physicians; Prescription drugs; Reading; Social networks; Substance abuse treatment; inappropriate prescribing; drug information services; health information management; evidence-based medicine
• ISSN: 0149-2918; 1879-114X
• DOI: 10.1016/j.clinthera.2015.12.019

Abstract Polypharmacy and complex drug treatment regimens are becoming increasingly common, which may lead to adverse drug reactions, drug interactions, medication nonadherence, and increasing costs and thus challenge the rational use of drugs. At the same time, the accessibility of drug information increases, and health care professionals may have limited opportunities and capabilities to search and critically evaluate drug information. Clinicians have reported difficulties in searching the best evidence and translating study findings into clinically meaningful information applicable to specific patients. Consequently, it remains a challenge to ensure the rational use of drugs in the years to come. Drug information centers (DICs) have been established to promote the rational use of drugs. One of the most important tasks of DICs is the question and answer services for health care professionals posing drug-related questions. DICs staffed by pharmacists and clinical pharmacologists hold expertise in searching for drug information and critical evaluation of the literature. The uniqueness in this service lies not only in the identification and interpretation of the scientific literature but also in the adaptation of the findings into specific clinical situations and the discussion of possible solutions with the enquirer. Thus, DICs could provide valuable decision support to the clinic. Taking into account the increasing number of possible drug-related questions that will arise today and in the future, the DICs will remain highly relevant in the years to come. However, the DICs must follow the developments in health information technology to disseminate relevant, unbiased drug information to old and new users of the service. Moreover, the DICs are important tools to counterbalance the drug information published by the pharmaceutical industry.